[Molecular and prenatal diagnosis of a family with Fanconi anemia by next generation sequencing]

Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2015 Apr;32(2):204-7. doi: 10.3760/cma.j.issn.1003-9406.2015.02.011.
[Article in Chinese]

Abstract

Objective: To provide prenatal diagnosis for a pregnant woman who had given birth to a child with Fanconi anemia with combined next-generation sequencing (NGS) and Sanger sequencing.

Methods: For the affected child, potential mutations of the FANCA gene were analyzed with NGS. Suspected mutation was verified with Sanger sequencing. For prenatal diagnosis, genomic DNA was extracted from cultured fetal amniotic fluid cells and subjected to analysis of the same mutations.

Results: A low-frequency frameshifting mutation c.989_995del7 (p.H330LfsX2, inherited from his father) and a truncating mutation c.3971C>T (p.P1324L, inherited from his mother) have been identified in the affected child and considered to be pathogenic. The two mutations were subsequently verified by Sanger sequencing. Upon prenatal diagnosis, the fetus was found to carry two mutations.

Conclusion: The combined next-generation sequencing and Sanger sequencing can reduce the time for diagnosis and identify subtypes of Fanconi anemia and the mutational sites, which has enabled reliable prenatal diagnosis of this disease.

Publication types

  • English Abstract
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Base Sequence
  • Child, Preschool
  • DNA Mutational Analysis
  • Fanconi Anemia / diagnosis
  • Fanconi Anemia / genetics*
  • Fanconi Anemia Complementation Group A Protein / genetics*
  • Female
  • Fetal Diseases / diagnosis
  • Fetal Diseases / genetics*
  • High-Throughput Nucleotide Sequencing
  • Humans
  • Male
  • Molecular Sequence Data
  • Mutation
  • Polymorphism, Single Nucleotide
  • Pregnancy
  • Prenatal Diagnosis

Substances

  • FANCA protein, human
  • Fanconi Anemia Complementation Group A Protein